UCB

BRUSSELS, Belgium, June 17, 2026 UCB has announced the publication of two significant peer-reviewed studies in Brain Communications demonstrating...

SHANGHAI and HONG KONG, China, June 10, 2026 Antengene announced that China’s National Medical Products Administration (NMPA) has approved...

SAN DIEGO, CALIFORNIA, May 03, 2026 UCB has announced a definitive agreement to acquire Candid Therapeutics in a transaction...

BRUSSELS, Belgium, April 17, 2026 UCB, a global biopharmaceutical leader, has announced a definitive agreement to acquire Neurona Therapeutics...

Brussels, Belgium & Atlanta, Georgia – March 24, 2026 Strategic Biologics Expansion to Strengthen Global Supply In a major...